Connect with us

Health

Ignite Amazonian Sunrise Drops [Review] Do Ignite Weight Loss Drops Really Work?

Published

 on

Want to shed extra body fat but don’t have time for the gym or restrictive diets? Your answer is Ignite Amazonian Sunrise Drops, and here is why.

Ignite Amazonian Sunrise Drops

A lot of people have trouble slimming down. You’re aware of this, but it doesn’t give you any solace to realize that many individuals face the same problem, right? What if you found an effective weight loss solution immune to the typical weight loss challenges?

Obesity is a deadly condition for what it does to your body and how easily it makes other conditions harm you. Excess weight makes you feel fatigued faster, hinders your mobility and endurance, and messes up your appearance. Low self-esteem is common with excess weight. Additionally, high blood pressure, cardiovascular complications, diabetes, and other diseases take advantage of obesity.

Genius Dog 336 x 280 - Animated

The standard solution is diet and exercise. Consistent work in the gym or on track yields excellent results, but it takes time and discipline. Your busy schedule may not leave adequate time for workouts. Additionally, other factors, such as genetics, may hinder your progress. Let us look at a third and more efficient option.

What Are Ignite’s Amazonian Sunrise Drops?

Ignite Amazonian Sunrise Drops are a weight loss product from IgniteDrops.com. The liquid weight loss formula is made using a traditional Amazonian recipe that guarantees results through the hormone BAM15. The hormone accelerates fat burning by up to a pound daily. It also suppresses appetite, thus reducing hunger pangs and food cravings.

The best thing about the Ignite Amazonian Drops is the natural formulation. The original recipe is based on ancient Amazonian research that unlocked the potency of BAM15, the sunrise hormone. Therefore, you won’t subject your body to harm as the product contains no artificial additives, preservatives, or other undesirable elements.

Research indicates that the Ignite Sunrise Drops are highly effective, have no side effects, and are gentle on your body. Ignite Drops give you a 150-day money-back guarantee, a testament to the authenticity of the drops.

Weight Loss With Age

As you get older, it becomes harder to lose weight, especially after 35 years. Diet and exercise help, but the commitment necessary for excellent results doesn’t leave room for much else in your life. Coincidentally, most people start working more while seated, begin to feel the effects of age, and generally have a slower metabolism. This only increases the difficulty of losing weight through dieting and exercise.

Diets have especially proven to be tough to follow. The most effective ones are too restrictive, affect your personality and mental state, and are costly for most. Meal prepping and clean eating are the new buzzwords that quickly become such annoying phrases that you can’t wait to be done with dieting. This is where BAM15 comes to the rescue.

Scientists discovered that people have the hormone BAM15, which is active in the morning. This is why it is also called the “sunrise hormone.” They observed the hormone, a small mitochondrial uncoupler, decreasing the body fat mass of mice without altering consumption, muscle mass, or body temperature. BAM15 was seen to reduce insulin resistance, oxidative stress, and inflammation. Therefore, BAM15 affects your body by prolonging the sunrise effect, where your all-day fat-burning capabilities are unlocked.

How Do Ignite Amazonian Sunrise Drops Work?

The Ignite Amazonian Sunrise Drops work by activating and prolonging the effects of the BAM15 hormone. Making the sunrise effect an all-day experience quickly burns fat away without restrictive diets and exercise. Moreover, your busy schedule won’t hinder your fat loss aspirations.

The most desirable effect of the Ignite Amazonian Sunrise Drops is their ability to initiate a natural weight loss process. There are no chemicals or synthetic hormones in its action. The drops only rejuvenate your body’s natural fat-burning mechanisms. Therefore, using the Ignite Amazonian Sunrise Drops has virtually no side effects.

Ignite Amazonian Sunrise Drops Natural Ingredients

These drops contain natural ingredients, each playing an essential role in your weight loss journey:

Astragalus Root

Astragalus root is the compound responsible for mitochondrial decoupling, thus allowing your body to keep burning fat. Turning your body into a fat-burning furnace naturally is the healthiest weight loss solution. Additionally, the root also helps to turn the melted fat into energy. Furthermore, the root balances your body’s natural insulin resistance, ensuring controlled blood glucose levels.

Astragalus root also helps increase your body’s collagen reserves, thus helping battle aging. Therefore, you’ll have better skin and hair. The compound also introduces anti-inflammatory properties, thus allowing you to reduce swelling and other inflammation effects.

Capsicum

Capsicum contains natural antioxidants that are associated with fat burning. These antioxidants increase your metabolic activity while also facilitating the conversion of fat into energy. Capsicum also possesses anti-inflammatory properties to help you deal with aches and pains. Furthermore, capsicum has cholesterol-balancing properties to help eliminate bad cholesterol and thus reduce the risk of blood pressure and cardiovascular complications.

African Mango

This component contains vitamins, nutrients, and minerals that help elevate metabolism. African mango also improves your cardiac health. Regular consumption of African mango extract significantly reduces the risk of cardiovascular diseases. Besides blood pressure stabilization, the African mango extract also balances hormone levels in your body, ensuring efficient metabolic processes.

Panax Ginseng

Panax ginseng is a testosterone production enhancer. Testosterone helps build lean muscle mass while burning fat. Therefore, increasing testosterone levels in your body results in faster fat burning and lean muscle mass. Your body will thus continue its natural fat-burning cycle. Additionally, Panax ginseng increases your body’s metabolic rate, which results in faster fat burning. Furthermore, this compound helps minimize levels, a state that encourages fat storage.

Grapefruit Seed

Grapefruit seeds increase the natural production of BAM15 in your body. By elevating BAM15 levels, your body will burn fat faster, thus accelerating fat loss. Additionally, this compound improves your immune system function.

Green Tea Leaf Extract

Green tea leaf extract is a powerful detoxifier that helps improve your gut health and keep other organs in better shape. The extract also contributes to minimizing high blood sugar levels. Green tea leaf extract is also fast-acting, increasing your body’s fat-burning abilities within a few days.

Maca Root

Maca root also increases BAM15 production, thus enabling accelerated fat burning by enhancing your fat oxidation rate. The compound also improves cognitive abilities by reducing anxiety, mood swings, and other mental complications.

Benefits of Consuming Ignite Amazonian Sunrise Drops

While weight loss is the primary reason to buy Ignite Amazonian Sunrise Drops, the product contains other desirable health benefits:

Improved Heart Health

As your body burns off excess fat, your heart will be less strained, thus functioning better. Additionally, these drops contain ingredients like African mango, which directly improve heart health.

Improved Metabolism

These drops also increase your basal metabolic rate, thus ensuring elevated fat burning at rest. Ingredients like green tea leaf extract help these drops attain that effect.

Manage Erectile Dysfunction

Ignite Amazonian Sunrise Drops contain ginseng, which helps unlock the full BAM15 potential. An incidental and welcome benefit is its effect on those with erectile dysfunction. While losing excess weight and improving cardiovascular health significantly contribute to better performance in bed, ginseng specifically benefits those with this condition. Therefore, you’ll have better sexual performance and the ability to sustain an erection for longer.

Helps Combat Menopause Symptoms

Another incidental and welcome benefit of consuming these drops comes from their Maca root extract content. Maca root helps speed up fat burning while soothing the symptoms of menopause. Menopause disrupts hormone production and function, thus leading to erratic weight gain. Maca root extracts balance hormone production and behavior, thus minimizing the effects of menopause.

Numb Pain Receptors

Ignite Amazonian Sunrise Drops bind with pain receptors, helping you feel less pain. Therefore, you can minimize the pain post workout, thus ensuring you sustain an active lifestyle. Combining the effects of these drops with an active lifestyle significantly improves your health and well-being.

Consistent Fat Burning

This is the primary benefit of consuming Ignite Amazonian Sunrise Drops. The company’s research reveals that these drops can help you lose weight without significantly altering your diet or schedule. Therefore, you can combat weight gain no matter how active or chaotic your life is.

Dosage and What to Expect

The manufacturer recommends taking 10 drops each morning. The drops come in a glass bottle with a dropper incorporated into the cap design. Therefore, you only need to unscrew the cap and squeeze the plunger at the top. You then squeeze out 10 drops under your tongue. Give the drops 30 to 60 seconds to seep into your bloodstream, then swallow the remainder.

The manufacturer promises a one-pound-a-day fat loss with a strict consumption schedule. However, results vary depending on age, gender, activity level, health status, and average daily movement activity.

Most customer reviews reveal the compound’s potency since all customers report some weight loss. Additionally, all customers report significantly higher weight loss than they experienced through diet and exercise. Therefore, expect these drops to work and, with proper management, to work as advertised.

Conclusion

Weight loss remains one of the biggest health challenges for many people. Their busier schedules and erratic diets further compound the problem. A healthy diet and exercise should help naturally reduce excess body fat. However, the world is hardly ideal, calling for a more practical approach.

Ignite Amazonian Sunrise Drops offer an optimal and natural solution, helping you lose weight without introducing side effects. The drops enhance your body’s natural fat-burning abilities while improving overall health. There is no better weight loss solution on the market than these drops.

Disclaimer: The views and opinions expressed in the above article are independent professional judgment of the experts and Canadanewsmedia does not take any responsibility, in any manner whatsoever, for the accuracy of their views. This should not be considered as a substitute for medical advice. Please consult your physician for more details. Ignite Amazonian Sunrise Drops shall be solely liable for the correctness, reliability of the content and/or compliance of applicable laws. The above is non-editorial content and The Tribune does not vouch, endorse or guarantee any of the above content, nor is it responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified.

 

Source link

Continue Reading

Health

Salt-inducible kinase 1-CREB-regulated transcription coactivator 1 signalling in the paraventricular nucleus of the hypothalamus plays a role in depression by regulating the hypothalamic–pituitary–adrenal axis | Molecular Psychiatry – Nature.com

Published

 on


Abstract

Elucidating the molecular mechanism underlying the hyperactivity of the hypothalamic–pituitary–adrenal axis during chronic stress is critical for understanding depression and treating depression. The secretion of corticotropin-releasing hormone (CRH) from neurons in the paraventricular nucleus (PVN) of the hypothalamus is controlled by salt-inducible kinases (SIKs) and CREB-regulated transcription co-activators (CRTCs). We hypothesised that the SIK-CRTC system in the PVN might contribute to the pathogenesis of depression. Thus, the present study employed chronic social defeat stress (CSDS) and chronic unpredictable mild stress (CUMS) models of depression, various behavioural tests, virus-mediated gene transfer, enzyme-linked immunosorbent assay, western blotting, co-immunoprecipitation, quantitative real-time reverse transcription polymerase chain reaction, and immunofluorescence to investigate this connection. Our results revealed that both CSDS and CUMS induced significant changes in SIK1-CRTC1 signalling in PVN neurons. Both genetic knockdown of SIK1 and genetic overexpression of CRTC1 in the PVN simulated chronic stress, producing a depression-like phenotype in naive mice, and the CRTC1-CREB-CRH pathway mediates the pro-depressant actions induced by SIK1 knockdown in the PVN. In contrast, both genetic overexpression of SIK1 and genetic knockdown of CRTC1 in the PVN protected against CSDS and CUMS, leading to antidepressant-like effects in mice. Moreover, stereotactic infusion of TAT-SIK1 into the PVN also produced beneficial effects against chronic stress. Furthermore, the SIK1-CRTC1 system in the PVN played a role in the antidepressant actions of fluoxetine, paroxetine, venlafaxine, and duloxetine. Collectively, SIK1 and CRTC1 in PVN neurons are closely involved in depression neurobiology, and they could be viable targets for novel antidepressants.

This is a preview of subscription content, access via your institution

Genius Dog 336 x 280 - Animated

Access options

/* style specs start */
styledisplay:none!important.LiveAreaSection-193358632 *align-content:stretch;align-items:stretch;align-self:auto;animation-delay:0s;animation-direction:normal;animation-duration:0s;animation-fill-mode:none;animation-iteration-count:1;animation-name:none;animation-play-state:running;animation-timing-function:ease;azimuth:center;backface-visibility:visible;background-attachment:scroll;background-blend-mode:normal;background-clip:borderBox;background-color:transparent;background-image:none;background-origin:paddingBox;background-position:0 0;background-repeat:repeat;background-size:auto auto;block-size:auto;border-block-end-color:currentcolor;border-block-end-style:none;border-block-end-width:medium;border-block-start-color:currentcolor;border-block-start-style:none;border-block-start-width:medium;border-bottom-color:currentcolor;border-bottom-left-radius:0;border-bottom-right-radius:0;border-bottom-style:none;border-bottom-width:medium;border-collapse:separate;border-image-outset:0s;border-image-repeat:stretch;border-image-slice:100%;border-image-source:none;border-image-width:1;border-inline-end-color:currentcolor;border-inline-end-style:none;border-inline-end-width:medium;border-inline-start-color:currentcolor;border-inline-start-style:none;border-inline-start-width:medium;border-left-color:currentcolor;border-left-style:none;border-left-width:medium;border-right-color:currentcolor;border-right-style:none;border-right-width:medium;border-spacing:0;border-top-color:currentcolor;border-top-left-radius:0;border-top-right-radius:0;border-top-style:none;border-top-width:medium;bottom:auto;box-decoration-break:slice;box-shadow:none;box-sizing:border-box;break-after:auto;break-before:auto;break-inside:auto;caption-side:top;caret-color:auto;clear:none;clip:auto;clip-path:none;color:initial;column-count:auto;column-fill:balance;column-gap:normal;column-rule-color:currentcolor;column-rule-style:none;column-rule-width:medium;column-span:none;column-width:auto;content:normal;counter-increment:none;counter-reset:none;cursor:auto;display:inline;empty-cells:show;filter:none;flex-basis:auto;flex-direction:row;flex-grow:0;flex-shrink:1;flex-wrap:nowrap;float:none;font-family:initial;font-feature-settings:normal;font-kerning:auto;font-language-override:normal;font-size:medium;font-size-adjust:none;font-stretch:normal;font-style:normal;font-synthesis:weight style;font-variant:normal;font-variant-alternates:normal;font-variant-caps:normal;font-variant-east-asian:normal;font-variant-ligatures:normal;font-variant-numeric:normal;font-variant-position:normal;font-weight:400;grid-auto-columns:auto;grid-auto-flow:row;grid-auto-rows:auto;grid-column-end:auto;grid-column-gap:0;grid-column-start:auto;grid-row-end:auto;grid-row-gap:0;grid-row-start:auto;grid-template-areas:none;grid-template-columns:none;grid-template-rows:none;height:auto;hyphens:manual;image-orientation:0deg;image-rendering:auto;image-resolution:1dppx;ime-mode:auto;inline-size:auto;isolation:auto;justify-content:flexStart;left:auto;letter-spacing:normal;line-break:auto;line-height:normal;list-style-image:none;list-style-position:outside;list-style-type:disc;margin-block-end:0;margin-block-start:0;margin-bottom:0;margin-inline-end:0;margin-inline-start:0;margin-left:0;margin-right:0;margin-top:0;mask-clip:borderBox;mask-composite:add;mask-image:none;mask-mode:matchSource;mask-origin:borderBox;mask-position:0 0;mask-repeat:repeat;mask-size:auto;mask-type:luminance;max-height:none;max-width:none;min-block-size:0;min-height:0;min-inline-size:0;min-width:0;mix-blend-mode:normal;object-fit:fill;object-position:50% 50%;offset-block-end:auto;offset-block-start:auto;offset-inline-end:auto;offset-inline-start:auto;opacity:1;order:0;orphans:2;outline-color:initial;outline-offset:0;outline-style:none;outline-width:medium;overflow:visible;overflow-wrap:normal;overflow-x:visible;overflow-y:visible;padding-block-end:0;padding-block-start:0;padding-bottom:0;padding-inline-end:0;padding-inline-start:0;padding-left:0;padding-right:0;padding-top:0;page-break-after:auto;page-break-before:auto;page-break-inside:auto;perspective:none;perspective-origin:50% 50%;pointer-events:auto;position:static;quotes:initial;resize:none;right:auto;ruby-align:spaceAround;ruby-merge:separate;ruby-position:over;scroll-behavior:auto;scroll-snap-coordinate:none;scroll-snap-destination:0 0;scroll-snap-points-x:none;scroll-snap-points-y:none;scroll-snap-type:none;shape-image-threshold:0;shape-margin:0;shape-outside:none;tab-size:8;table-layout:auto;text-align:initial;text-align-last:auto;text-combine-upright:none;text-decoration-color:currentcolor;text-decoration-line:none;text-decoration-style:solid;text-emphasis-color:currentcolor;text-emphasis-position:over right;text-emphasis-style:none;text-indent:0;text-justify:auto;text-orientation:mixed;text-overflow:clip;text-rendering:auto;text-shadow:none;text-transform:none;text-underline-position:auto;top:auto;touch-action:auto;transform:none;transform-box:borderBox;transform-origin:50% 50%0;transform-style:flat;transition-delay:0s;transition-duration:0s;transition-property:all;transition-timing-function:ease;vertical-align:baseline;visibility:visible;white-space:normal;widows:2;width:auto;will-change:auto;word-break:normal;word-spacing:normal;word-wrap:normal;writing-mode:horizontalTb;z-index:auto;-webkit-appearance:none;-moz-appearance:none;-ms-appearance:none;appearance:none;margin:0.LiveAreaSection-193358632width:100%.LiveAreaSection-193358632 .login-option-buyboxdisplay:block;width:100%;font-size:17px;line-height:30px;color:#222;padding-top:30px;font-family:Harding,Palatino,serif.LiveAreaSection-193358632 .additional-access-optionsdisplay:block;font-weight:700;font-size:17px;line-height:30px;color:#222;font-family:Harding,Palatino,serif.LiveAreaSection-193358632 .additional-login>li:not(:first-child)::beforetransform:translateY(-50%);content:””;height:1rem;position:absolute;top:50%;left:0;border-left:2px solid #999.LiveAreaSection-193358632 .additional-login>li:not(:first-child)padding-left:10px.LiveAreaSection-193358632 .additional-login>lidisplay:inline-block;position:relative;vertical-align:middle;padding-right:10px.BuyBoxSection-683559780display:flex;flex-wrap:wrap;flex:1;flex-direction:row-reverse;margin:-30px -15px 0.BuyBoxSection-683559780 .box-innerwidth:100%;height:100%.BuyBoxSection-683559780 .readcube-buyboxbackground-color:#f3f3f3;flex-shrink:1;flex-grow:1;flex-basis:255px;background-clip:content-box;padding:0 15px;margin-top:30px.BuyBoxSection-683559780 .subscribe-buyboxbackground-color:#f3f3f3;flex-shrink:1;flex-grow:4;flex-basis:300px;background-clip:content-box;padding:0 15px;margin-top:30px.BuyBoxSection-683559780 .subscribe-buybox-nature-plusbackground-color:#f3f3f3;flex-shrink:1;flex-grow:4;flex-basis:100%;background-clip:content-box;padding:0 15px;margin-top:30px.BuyBoxSection-683559780 .title-readcubedisplay:block;margin:0;margin-right:20%;margin-left:20%;font-size:24px;line-height:32px;color:#222;padding-top:30px;text-align:center;font-family:Harding,Palatino,serif.BuyBoxSection-683559780 .title-buyboxdisplay:block;margin:0;margin-right:29%;margin-left:29%;font-size:24px;line-height:32px;color:#222;padding-top:30px;text-align:center;font-family:Harding,Palatino,serif.BuyBoxSection-683559780 .title-asia-buyboxdisplay:block;margin:0;margin-right:5%;margin-left:5%;font-size:24px;line-height:32px;color:#222;padding-top:30px;text-align:center;font-family:Harding,Palatino,serif.BuyBoxSection-683559780 .asia-linkcolor:#069;cursor:pointer;text-decoration:none;font-size:1.05em;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:1.05em6.BuyBoxSection-683559780 .access-readcubedisplay:block;margin:0;margin-right:10%;margin-left:10%;font-size:14px;color:#222;padding-top:10px;text-align:center;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:20px.BuyBoxSection-683559780 .access-asia-buyboxdisplay:block;margin:0;margin-right:5%;margin-left:5%;font-size:14px;color:#222;padding-top:10px;text-align:center;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:20px.BuyBoxSection-683559780 .access-buyboxdisplay:block;margin:0;margin-right:30%;margin-left:30%;font-size:14px;color:#222;opacity:.8px;padding-top:10px;text-align:center;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:20px.BuyBoxSection-683559780 .usps-buyboxdisplay:block;margin:0;margin-right:30%;margin-left:30%;font-size:14px;color:#222;opacity:.8px;text-align:center;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:20px.BuyBoxSection-683559780 .price-buyboxdisplay:block;font-size:30px;color:#222;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;padding-top:30px;text-align:center.BuyBoxSection-683559780 .price-fromfont-size:14px;padding-right:10px;color:#222;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:20px.BuyBoxSection-683559780 .issue-buyboxdisplay:block;font-size:13px;text-align:center;color:#222;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:19px.BuyBoxSection-683559780 .no-price-buyboxdisplay:block;font-size:13px;line-height:18px;text-align:center;padding-right:10%;padding-left:10%;padding-bottom:20px;padding-top:30px;color:#222;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif.BuyBoxSection-683559780 .vat-buyboxdisplay:block;margin-top:5px;margin-right:20%;margin-left:20%;font-size:11px;color:#222;padding-top:10px;padding-bottom:15px;text-align:center;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;line-height:17px.BuyBoxSection-683559780 .button-containerdisplay:flex;padding-right:20px;padding-left:20px;justify-content:center.BuyBoxSection-683559780 .button-container>*flex:1px.BuyBoxSection-683559780 .button-container>a:hover,.Button-1078489254:hover,.Button-2808614501:hovertext-decoration:none.BuyBoxSection-683559780 .readcube-buttonbackground:#fff;margin-top:30px.BuyBoxSection-683559780 .button-asiabackground:#069;border:1px solid #069;border-radius:0;cursor:pointer;display:block;padding:9px;outline:0;text-align:center;text-decoration:none;min-width:80px;margin-top:75px.BuyBoxSection-683559780 .button-label-asia,.ButtonLabel-3296148077,.ButtonLabel-1566022830display:block;color:#fff;font-size:17px;line-height:20px;font-family:-apple-system,BlinkMacSystemFont,”Segoe UI”,Roboto,Oxygen-Sans,Ubuntu,Cantarell,”Helvetica Neue”,sans-serif;text-align:center;text-decoration:none;cursor:pointer.Button-1078489254,.Button-2808614501background:#069;border:1px solid #069;border-radius:0;cursor:pointer;display:block;padding:9px;outline:0;text-align:center;text-decoration:none;min-width:80px;max-width:320px;margin-top:10px.Button-1078489254 .readcube-label,.Button-2808614501 .readcube-labelcolor:#069
/* style specs end */

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Exposure to chronic stress notably modulated SIK1-CRTC1 signalling in the PVN of mice.
Fig. 2: AAV-mediated genetic knockdown of SIK1 in the PVN of naive mice produced various depression-like symptoms.
Fig. 3: AAV-mediated genetic overexpression of SIK1 in the PVN exerted significant antidepressant-like effects in mice.
Fig. 4: AAV-mediated genetic overexpression of SIK1 in the PVN exerted significant protective effects against chronic stress on the SIK1-CRTC1-CRH pathway in the PVN and the BDNF signalling cascade in the hippocampus and mPFC.
Fig. 5: Repeated administration of fluoxetine and venlafaxine notably reversed the effects of chronic stress on the SIK1-CRTC1-CRH pathway in the PVN.
Fig. 6: Schematic representation of a suggested model describing the role of SIK1-CRTC1 signalling in PVN neurons in chronic stress-induced depression is provided.

Data availability

The authors declare that all data supporting the findings of this study are available within the paper and its Supplementary information files.

References

  1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.

    Article 
    PubMed 

    Google Scholar
     

  2. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40.

    Article 
    PubMed 

    Google Scholar
     

  3. Fava M, Kendler KS. Major depressive disorder. Neuron. 2000;28:335–41.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  4. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  5. Leistner C, Menke A. Hypothalamic-pituitary-adrenal axis and stress. Handb Clin Neurol. 2020;175:55–64.

    Article 
    PubMed 

    Google Scholar
     

  6. Aguilera G, Liu Y. The molecular physiology of CRH neurons. Front Neuroendocrinol. 2012;33:67–84.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  7. Jurek B, Slattery DA, Hiraoka Y, Liu Y, Nishimori K, Aguilera G, et al. Oxytocin regulates stress-induced Crf gene transcription through CREB-regulated transcription coactivator 3. J Neurosci. 2015;35:12248–60.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  8. Liu Y, Coello AG, Grinevich V, Aguilera G. Involvement of transducer of regulated cAMP response element-binding protein activity on corticotropin releasing hormone transcription. Endocrinology. 2010;151:1109–18.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  9. Liu Y, Knobloch HS, Grinevich V, Aguilera G. Stress induces parallel changes in corticotropin releasing hormone (CRH) Transcription and nuclear translocation of transducer of regulated cAMP response element-binding activity 2 in hypothalamic CRH neurons. J Neuroendocrinol. 2011;23:216–23.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  10. Liu Y, Poon V, Sanchez-Watts G, Watts AG, Takemori H, Aguilera G. Salt-inducible kinase is involved in the regulation of corticotropin-releasing hormone transcription in hypothalamic neurons in rats. Endocrinology. 2012;153:223–33.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  11. Martín F, Núñez C, Marín MT, Laorden ML, Kovács KJ, Milanés MV. Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal. PLoS One. 2012;7:e31119.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  12. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, et al. TORCs: transducers of regulated CREB activity. Mol Cell. 2003;12:413–23.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  13. Takemori H, Kajimura J, Okamoto M. TORC-SIK cascade regulates CREB activity through the basic leucine zipper domain. FEBS J. 2007;274:3202–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  14. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, et al. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J. 2006;273:2730–48.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  15. Takemori H, Okamoto M. Regulation of CREB-mediated gene expression by salt inducible kinase. J Steroid Biochem Mol Biol. 2008;108:287–91.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  16. Saura CA, Cardinaux JR. Emerging roles of CREB-regulated transcription coactivators in brain physiology and pathology. Trends Neurosci. 2017;40:720–33.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  17. Jiang B, Wang H, Wang JL, Wang YJ, Zhu Q, Wang CN, et al. Hippocampal salt-inducible kinase 2 plays a role in depression via the CREB-regulated transcription coactivator 1-cAMP response element binding-brain-derived neurotrophic factor pathway. Biol Psychiatry. 2019;85:650–66.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  18. Wang Z, Takemori H, Halder SK, Nonaka Y, Okamoto M. Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett. 1999;453:135–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  19. Choi S, Kim W, Chung J. Drosophila salt-inducible kinase (SIK) regulates starvation resistance through cAMP-response element-binding protein (CREB)-regulated transcription coactivator (CRTC). J Biol Chem. 2011;286:2658–64.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  20. Liu Y, Tang W, Ji C, Gu J, Chen Y, Huang J, et al. The selective SIK2 inhibitor ARN-3236 produces strong antidepressant-like efficacy in mice via the hippocampal CRTC1-CREB-BDNF pathway. Front Pharm. 2021;11:624429.

    Article 

    Google Scholar
     

  21. Xu D, Sun Y, Wang C, Wang H, Wang Y, Zhao W, et al. Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine. Neuropharmacology. 2018;128:181–95.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  22. Gao TT, Wang Y, Liu L, Wang JL, Wang YJ, Guan W, et al. LIMK1/2 in the mPFC plays a role in chronic stress-induced depressive-like effects in mice. Int J Neuropsychopharmacol. 2020;23:821–36.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  23. Tang WQ, Liu Y, Ji CH, Gu JH, Chen YM, Huang J, et al. Virus-mediated decrease of LKB1 activity in the mPFC diminishes stress-induced depressive-like behaviors in mice. Biochem Pharm. 2022;197:114885.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  24. Antoniuk S, Bijata M, Ponimaskin E, Wlodarczyk J. Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability. Neurosci Biobehav Rev. 2019;99:101–16.

    Article 
    PubMed 

    Google Scholar
     

  25. Wang W, Liu W, Duan D, Bai H, Wang Z, Xing Y. Chronic social defeat stress mouse model: current view on its behavioral deficits and modifications. Behav Neurosci. 2021;135:326–35.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  26. Masi G, Brovedani P. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs. 2011;25:913–31.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  27. Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011;476:458–61.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  28. Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev. 2014;38:173–92.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  29. Liu J, Meng F, Dai J, Wu M, Wang W, Liu C, et al. The BDNF-FoxO1 axis in the medial prefrontal cortex modulates depressive-like behaviors induced by chronic unpredictable stress in postpartum female mice. Mol Brain. 2020;13:91.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  30. Jiang Z, Zhu Z, Zhao M, Wang W, Li H, Liu D, et al. H3K9me2 regulation of BDNF expression in the hippocampus and medial prefrontal cortex is involved in the depressive-like phenotype induced by maternal separation in male rats. Psychopharmacology (Berl). 2021;238:2801–13.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  31. Seasholtz AF, Thompson RC, Douglass JO. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol. 1988;2:1311–9.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  32. Adler GK, Smas CM, Fiandaca M, Frim DM, Majzoub JA. Regulated expression of the human corticotropin releasing hormone gene by cyclic AMP. Mol Cell Endocrinol. 1990;70:165–74.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  33. Guardiola-Diaz HM, Boswell C, Seasholtz AF. The cAMP-responsive element in the corticotrophin releasing hormone gene mediates transcriptional regulation by depolarization. J Biol Chem. 1994;269:14784–91.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  34. Cheng YH, Nicholson RC, King B, Chan EC, Fitter JT, Smith R. Corticotropin-releasing hormone gene expression in primary placental cells is modulated by cyclic adenosine 3′,5′-monophosphate. J Clin Endocrinol Metab. 2000;85:1239–44.

    CAS 
    PubMed 

    Google Scholar
     

  35. Liu Y, Kamitakahara A, Kim AJ, Aguilera G. Cyclic adenosine 3′,5′-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription. Endocrinology. 2008;149:3512–20.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  36. Hashimoto YK, Satoh T, Okamoto M, Takemori H. Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J Cell Biochem. 2008;104:1724–39.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  37. Darling NJ, Cohen P. Nuts and bolts of the salt-inducible kinases (SIKs). Biochem J. 2021;478:1377–97.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  38. Takemori H, Katoh Y, Horike N, Doi J, Okamoto M. ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells. J Biol Chem. 2002;277:42334–43.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  39. Takemori H, Doi J, Horike N, Katoh Y, Min L, Lin XZ, et al. Salt-inducible kinase-mediated regulation of steroidogenesis at the early stage of ACTH-stimulation. J Steroid Biochem Mol Biol. 2003;85:397–400.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  40. Luo X, Kiss A, Makara G, Lolait SJ, Aguilera G. Stress-specific regulation of corticotrophin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol. 1994;6:689–96.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  41. Rivest S, Laflamme N, Nappi RE. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci. 1995;15:2680–95.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  42. Lehmann ML, Mustafa T, Eiden AM, Herkenham M, Eiden LE. PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress. Psychoneuroendocrinology. 2013;38:702–15.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  43. Mustafa T. Pituitary adenylate cyclase-activating polypeptide (PACAP): a master regulator in central and peripheral stress responses. Adv Pharm. 2013;68:445–57.

    Article 
    CAS 

    Google Scholar
     

  44. Jiang SZ, Eiden LE. Activation of the HPA axis and depression of feeding behavior induced by restraint stress are separately regulated by PACAPergic neurotransmission in the mouse. Stress. 2016;19:374–82.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  45. Watts AG, Sanchez-Watts G, Liu Y, Aguilera G. The distribution of messenger RNAs encoding the three isoforms of the transducer of regulated cAMP responsive element binding protein activity in the rat forebrain. J Neuroendocrinol. 2011;23:754–66.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  46. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol. 1980;194:555–70.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  47. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharm Toxicol. 2004;44:525–57.

    Article 
    CAS 

    Google Scholar
     

  48. Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6:603–21.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  49. Herman JP, Prewitt CM, Cullinan WE. Neuronal circuit regulation of the hypothalamo-pituitary adrenocortical stress axis. Crit Rev Neurobiol. 1996;10:371–94.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  50. Palkovits M, Baffi JS, Pacak K. The role of ascending neuronal pathways in stress-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. J Neuroendocrinol. 1999;11:529–39.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  51. Flak JN, Ostrander MM, Tasker JG, Herman JP. Chronic stress-induced neurotransmitter plasticity in the PVN. J Comp Neurol. 2009;517:156–65.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  52. Evanson NK, Herman JP. Role of paraventricular nucleus glutamate signaling in regulation of HPA axis stress responses. Interdiscip Inf Sci. 2015;21:253–60.

    PubMed 
    PubMed Central 

    Google Scholar
     

  53. Berdeaux R, Goebel N, Banaszynski L, Takemori H, Wandless T, Shelton GD, et al. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med. 2007;13:597–603.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  54. van der Linden AM, Nolan KM, Sengupta P. KIN-29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDAC. EMBO J. 2007;26:358–70.

    Article 
    PubMed 

    Google Scholar
     

  55. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32–42.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  56. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT, Alvarez JG, et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell. 2011;145:607–21.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  57. Finsterwald C, Carrard A, Martin JL. Role of salt-inducible kinase 1 in the activation of MEF2-dependent transcription by BDNF. PLoS One. 2013;8:e54545.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  58. Wein MN, Foretz M, Fisher DE, Xavier RJ, Kronenberg HM. Salt inducible kinases: physiology, regulation by cAMP, and therapeutic potential. Trends Endocrinol Metab. 2018;29:723–35.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  59. Goh SL, Looi Y, Shen H, Fang J, Bodner C, Houle M, et al. Transcriptional activation by MEIS1A in response to protein kinase A signaling requires the transducers of regulated CREB family of CREB co-activators. J Biol Chem. 2009;284:18904–12.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  60. Yong Kim S, Jeong S, Chah KH, Jung E, Baek KH, Kim ST, et al. Salt-inducible kinases 1 and 3 negatively regulate Toll-like receptor 4-mediated signal. Mol Endocrinol. 2013;27:1958–68.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  61. Böer U, Eglins J, Krause D, Schnell S, Schöfl C, Knepel W. Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain. Biochem J. 2007;408:69–77.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  62. Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011;12:141–51.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  63. Massart R, Mongeau R, Lanfumey L. Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. Philos Trans R Soc Lond B Biol Sci. 2012;367:2485–94.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  64. Dale E, Bang-Andersen B, Sánchez C. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharm. 2015;95:81–97.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  65. Boku S, Nakagawa S, Toda H, Hishimoto A. Neural basis of major depressive disorder: beyond monoamine hypothesis. Psychiatry Clin Neurosci. 2018;72:3–12.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  66. Jensen JB, Jessop DS, Harbuz MS, Mørk A, Sánchez C, Mikkelsen JD. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol. 1999;11:465–71.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  67. Jongsma ME, Bosker FJ, Cremers TI, Westerink BH, den Boer JA. The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:738–44.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  68. Goel N, Innala L, Viau V. Sex differences in serotonin (5-HT) 1A receptor regulation of HPA axis and dorsal raphe responses to acute restraint. Psychoneuroendocrinology. 2014;40:232–41.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  69. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003;24:151–80.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  70. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10:397–409.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

Download references

Acknowledgements

This work was supported by four grants from the National Natural Science Foundation of China (Nos. 82071519, 81873795, 81900551, and 82001606).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualisation: BJ. Methodology: YW, LL, J-HG, C-NW, WG, YL, W-QT, C-HJ, Y-MC, and JH. Investigation: YW, LL, J-HG, YL, W-QT, C-HJ, Y-MC, JH, W-YL, T-SS, W-JC, and B-LZ. Formal analysis: BJ. Resources: BJ, C-NW, and WG. Writing—original draft: BJ. Writing—review and editing: BJ. Visualisation: BJ. Supervision: BJ. Project administration: BJ. Funding acquisition: BJ, C-NW, and WG.

Corresponding author

Correspondence to
Bo Jiang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Liu, L., Gu, JH. et al. Salt-inducible kinase 1-CREB-regulated transcription coactivator 1 signalling in the paraventricular nucleus of the hypothalamus plays a role in depression by regulating the hypothalamic–pituitary–adrenal axis.
Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01881-4

Download citation

  • Received: 05 August 2022

  • Revised: 30 October 2022

  • Accepted: 09 November 2022

  • Published: 25 November 2022

  • DOI: https://doi.org/10.1038/s41380-022-01881-4

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Adblock test (Why?)



Source link

Continue Reading

Health

Deadly Bird Flu Outbreak Is The Worst In U.S. History – Yahoo Singapore News

Published

 on


An ongoing outbreak of a deadly strain of bird flu has now killed more birds than any past flare-up in U.S. history.

The virus, known as highly pathogenic avian influenza, has led to the deaths of 50.54 million domestic birds in the country this year, according to Agriculture Department data reported by Reuters on Thursday. That figure represents birds like chickens, ducks and turkeys from commercial poultry farms, backyard flocks and facilities such as petting zoos.

The count surpasses the previous record of 50.5 million dead birds from a 2015 outbreak, according to Reuters.

Genius Dog 336 x 280 - Animated

Separately, USDA data shows at least 3,700 confirmed cases among wild birds.

Turkeys in a barn on a poultry farm.

Turkeys in a barn on a poultry farm.

Turkeys in a barn on a poultry farm.

On farms, some birds die from the flu directly, while in other cases, farmers kill their entire flocks to prevent the virus from spreading after one bird tests positive. Such farmers have occasionally drawn condemnation from animal welfare advocates for using a culling method known as “ventilation shutdown plus,” which involves sealing off the airways to a barn and pumping in heat to kill the animals.

The virus has raged through Europe and North America since 2021. A variety of wild birds have been affected worldwide, including bald eagles, vultures and seabirds. This month, Peru reported its first apparent outbreak of highly pathogenic avian influenza after 200 dead pelicans were found on a beach.

Pelicans suspected to have died from highly pathogenic avian influenza are seen on a beach in Lima, Peru, on Nov. 24.Pelicans suspected to have died from highly pathogenic avian influenza are seen on a beach in Lima, Peru, on Nov. 24.

Pelicans suspected to have died from highly pathogenic avian influenza are seen on a beach in Lima, Peru, on Nov. 24.

Pelicans suspected to have died from highly pathogenic avian influenza are seen on a beach in Lima, Peru, on Nov. 24.

The migration of infected wild birds has been a major cause of the spread. Health and wildlife officials urge anyone who keeps domestic birds to prevent contact with their wild counterparts.

While health experts do not generally consider highly pathogenic avian influenza to be a major risk to mammals, a black bear cub in Alaska was euthanized earlier this month after contracting the virus. Wildlife veterinarian Dr. Kimberlee Beckmen told the Juneau Empire newspaper that the young cub had a weak immune system.

Over the summer, avian flu also spread among seals in Maine, which the National Oceanic and Atmospheric Administration believed contributed to an unusually high number of seal deaths.

The Centers for Disease Control and Prevention states that the risk “to the general public” from the bird flu outbreak is low. However, the agency recommends precautions like wearing personal protective equipment and thoroughly washing hands for people who have prolonged contact with birds that may be infected.

In April, a Colorado prisoner working at a commercial farm became the first person in the U.S. to test positive for the new strain, though he was largely asymptomatic.

Related…

Adblock test (Why?)



Source link

Continue Reading

Health

Successful tests in animal models pave way for strategy for universal flu vaccine – Deccan Herald

Published

 on


An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, according to a study.

This could serve one day as a general preventative measure against future flu pandemics, the researchers from University of Pennsylvania, US, said.

According to the study, tests in animal models showed that the vaccine dramatically reduced signs of illness and protected from death, even when the animals were exposed to flu strains different from those used in making the vaccine.

Genius Dog 336 x 280 - Animated

The “multivalent” vaccine, which the researchers described in a paper published in the journal Science, used the same messenger ribonucleic acid (mRNA) technology employed in the Pfizer and Moderna SARS-CoV-2 vaccines, the study said.

This mRNA technology that enabled those Covid-19 vaccines was pioneered at Penn, the study said.

Also Read | Covid-19 may increase risk of stroke in children: Study

“The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs,” said study senior author Scott Hensley.

Influenza viruses periodically cause pandemics with enormous death tolls. The best known of these was the 1918-19 “Spanish flu” pandemic, which killed at least tens of millions of people worldwide.

Flu viruses can circulate in birds, pigs, and other animals, and pandemics can start when one of these strains jumps to humans and acquires mutations that adapt it better for spreading among humans.

Also Read | Remdesivir could reduce Covid-19 mortality if given early: Study

Current flu vaccines are merely “seasonal” vaccines that protect against recently circulating strains, but would not be expected to protect against new, pandemic strains. The strategy employed by the Penn researchers is to vaccinate using immunogens – a type of antigen that stimulates immune responses – from all known influenza subtypes in order to elicit broad protection, the study said.

The vaccine is not expected to provide “sterilizing” immunity that completely prevents viral infections. Instead, the new study showed that the vaccine elicited a memory immune response that can be quickly recalled and adapted to new pandemic viral strains, significantly reducing severe illness and death from infections.

“It would be comparable to first-generation SARS-CoV-2 mRNA vaccines, which were targeted to the original Wuhan strain of the coronavirus.

“Against later variants such as Omicron, these original vaccines did not fully block viral infections, but they continue to provide durable protection against severe disease and death,” said Hensley.

The experimental vaccine, when injected and taken up by the cells of recipients, started producing copies of a key flu virus protein, the hemagglutinin protein, for all twenty influenza hemagglutinin subtypes—H1 through H18 for influenza A viruses, and two more for influenza B viruses.

“For a conventional vaccine, immunizing against all these subtypes would be a major challenge, but with mRNA technology it’s relatively easy,” Hensley said.

In mice, the mRNA vaccine elicited high levels of antibodies, which stayed elevated for at least four months, and reacted strongly to all 20 flu subtypes. Moreover, the vaccine seemed relatively unaffected by prior influenza virus exposures, which can skew immune responses to conventional influenza vaccines.

The researchers observed that the antibody response in the mice was strong and broad, whether or not the animals had been exposed to flu virus before.

Hensley and his colleagues currently are designing human clinical trials, he said. The researchers envision that, if those trials are successful, the vaccine may be useful for eliciting long-term immune memory against all influenza subtypes in people of all age groups, including young children.

“We think this vaccine could significantly reduce the chances of ever getting a severe flu infection,” Hensley said.

In principle, he added, the same multivalent mRNA strategy can be used for other viruses with pandemic potential, including coronaviruses.

Adblock test (Why?)



Source link

Continue Reading

Trending